YD Bio Ltd (YDES) stock

YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 5/30

$4.88−0.32 (-6.06%)

Close on Nov 13, 2026Market cap $345.45MP/E –Yield –

YD Bio ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

YD Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is YDES.

Revenue growth16.9% · median -51.3%

Gross margin28.1% · median 46.4%

Operating margin-883.3% · median -2525.0%

Net margin-1392.6% · median -1578.8%

Advertisement
300 × 250

See a number that looks wrong?